1. Home
  2. COGT vs PSIX Comparison

COGT vs PSIX Comparison

Compare COGT & PSIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COGT
  • PSIX
  • Stock Information
  • Founded
  • COGT 2014
  • PSIX 1985
  • Country
  • COGT United States
  • PSIX United States
  • Employees
  • COGT N/A
  • PSIX N/A
  • Industry
  • COGT Biotechnology: Pharmaceutical Preparations
  • PSIX Industrial Machinery/Components
  • Sector
  • COGT Health Care
  • PSIX Industrials
  • Exchange
  • COGT Nasdaq
  • PSIX Nasdaq
  • Market Cap
  • COGT 2.3B
  • PSIX 2.0B
  • IPO Year
  • COGT 2018
  • PSIX N/A
  • Fundamental
  • Price
  • COGT $16.30
  • PSIX $85.62
  • Analyst Decision
  • COGT Strong Buy
  • PSIX Strong Buy
  • Analyst Count
  • COGT 12
  • PSIX 1
  • Target Price
  • COGT $22.00
  • PSIX $37.00
  • AVG Volume (30 Days)
  • COGT 2.4M
  • PSIX 563.4K
  • Earning Date
  • COGT 10-31-2025
  • PSIX 11-07-2025
  • Dividend Yield
  • COGT N/A
  • PSIX N/A
  • EPS Growth
  • COGT N/A
  • PSIX 146.48
  • EPS
  • COGT N/A
  • PSIX 4.81
  • Revenue
  • COGT N/A
  • PSIX $597,494,000.00
  • Revenue This Year
  • COGT N/A
  • PSIX $29.80
  • Revenue Next Year
  • COGT N/A
  • PSIX $11.99
  • P/E Ratio
  • COGT N/A
  • PSIX $17.80
  • Revenue Growth
  • COGT N/A
  • PSIX 40.10
  • 52 Week Low
  • COGT $3.72
  • PSIX $15.30
  • 52 Week High
  • COGT $17.15
  • PSIX $121.78
  • Technical
  • Relative Strength Index (RSI)
  • COGT 61.29
  • PSIX 47.68
  • Support Level
  • COGT $14.20
  • PSIX $79.89
  • Resistance Level
  • COGT $16.50
  • PSIX $89.20
  • Average True Range (ATR)
  • COGT 0.84
  • PSIX 5.63
  • MACD
  • COGT -0.07
  • PSIX 0.10
  • Stochastic Oscillator
  • COGT 71.19
  • PSIX 49.49

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About PSIX Power Solutions International Inc. Common Stock

Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States.

Share on Social Networks: